Biotechnology Innovation Organization (BIO)
1225 Eye Street, NW
About Biotechnology Innovation Organization (BIO)
The Biotechnology Innovation Organization (BIO) is the largest trade organization to serve and represent the emerging biotechnology industry in the United States and around the globe. The organization's leadership and service-oriented guidance have helped advance the industry and bring the benefits of biotechnology to the people of the world.
As the leading voice for the biotechnology industry, BIO represents companies of all sizes engaged in the development of products and services in the areas of agriculture, biomedicine, diagnostics, food, energy and environmental applications. Though biotechnology's future is bright, the industry's success will depend on the commitment, energy and direction of the group that helps guide its growth. BIO is a vital forum and an invaluable focal point to bring together the resources and expertise to meet critical challenges and serve the needs of its members.
3329 articles with Biotechnology Innovation Organization (BIO)
Biocom California Joins Legal Challenge to Department of Health and Human Services’ Most Favored Nation Interim Final Rule for Drug Pricing
Biocom California, the association representing the California life science industry, joined the Biotechnology Innovation Organization and the California Life Sciences Association in filing a challenge against the Department of Health and Human Services’ recent Most-Favored Nation Interim Final Rule.
The Biotechnology Innovation Organization announced a new, strategic direction that will help guide it to achieving long-term goals while maintaining responsiveness to changing political headwinds.
The Biotechnology Innovation Organization (BIO) announced today the retirement of Senior Vice President and Chief Financial Officer (CFO), Yvette White-Wiggins, after a distinguished 18-year career with the organization. White-Wiggins rose through the ranks at BIO and served as CFO since 2016, building a solid financial infrastructure that will serve the org
The Biotechnology Innovation Organization awarded Roy Cooper, Governor of North Carolina, with its 2020 Governor of the Year Award. Governor Cooper was presented the award virtually at NCBIO’s 2020 Annual Meeting.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 11, 2020.
Ensuring Scientific Justice by Building Bridges to Minority Communities is Centerpiece of BIOEquality Agenda
New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization
The Biotechnology Innovation Organization (BIO) today announced winners of the Start-up Stadium competition held during BIO Digital in June. Pre-recorded presentation videos submitted by 30 finalists were evaluated by expert judges with entrepreneurial, investment, start-up, economic development, capital forma
COVID-19-related testimonies will continue in Congress today, with representatives from the Biotechnology Innovation Organization (BIO) expected to address the current pandemic as well as key priorities that will need to be in place in order to effectively respond to the next global viral threat.
The Biotechnology Innovation Organization released new data on the bioscience industry in the United States this week during the BIO Digital conference.
Although clinical trials are often performed throughout different parts of the world, often their demographic makeup—the gender, age and race of participants—has a certain kind of uniformity.
The Biotechnology Innovation Organization (BIO) today released its ninth biennial report, “ The Bioscience Economy: Propelling Life-Saving Treatments, Supporting State & Local Communities ,” which highlights Michigan as a top state for the biosciences. The report studies the state of the U.S. bioscience industry and its associated inno
Fauci, a longtime infectious disease expert, said COVID-19 is the stuff of nightmares in the way it has quickly spread across the globe, infected millions of people and contributed to the deaths of more than 408,000 people.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 10, 2020.
The annual Biotechnology Innovation Organization meeting kicked off Monday with the proverbial passing of the baton from longtime head Jim Greenwood to Michelle McMurry-Heath, who was tapped to take over the organization last month.
The Biotechnology Innovation Organization released new data on the bioscience industry in the United States.
This year’s event, which kicks off June 8, will have a different look as an entirely digital conference.
Dr. Anthony Fauci, Dr. Moncef Slaoui and Top COVID-19 Thought Leaders Take Stage During BIO Digital Week
Convening national experts at the epicenter of vaccine development for COVID-19 while presenting critical conversations on the state of the biopharma industry amid the pandemic
5/15/2020Pharma, biotech and life sciences companies bolster their executive teams and boards with these Movers & Shakers.
Immunologist Michelle McMurry-Heath is Selected for Her Global Leadership and Commitment to Innovation and Patients Former FDA Official Will Succeed Industry Leader Jim Greenwood on June 1 as Leader of World’s Largest Biotechnology Advocacy Association
Amid COVID-19 pandemic, BIO Digital 2020 convenes virtual gathering of the global biotechnology community